Clotblog with Dr Samuel GoldhaberView all posts »
CURRENT OASIS-7: Doubling the clopidogrel dose in ACS patients undergoing PCIOct 22, 2009 09:30 EDT
The CURRENT OASIS-7 trial published during ESC showed a remarkable reduction in myocardial infarction and in-stent thrombosis for patients whose loading dose of clopidogrel was doubled. With a dataset of over 17,000 patients, the results are remarkable and uptake in cath labs has been rapid. With time, how will the OASIS-7 regimen compare with novel antiplatelet agents and approaches to antiplatelet testing?